Back to search results

Evaluating a Nitric Oxide Generator, Nebivolol as a Disease Modifier in Patients With Diabetic Neuropathy.

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Diabetic Neuropathy Peripheral

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • St John's Medical College Hospital, Bangalore, Karnataka, India

    Contact: Study coordinator (Deepak Kamath, MBBS, MD) · kamath.deepak@sjri.res.in · 9945519522
    Contact: Principal Investigator (Belinda George, MD,DM)

  • St John's Research Institute, Bangalore, Karntakaka, India

    Contact: Study coordinator (Dr Deepak Y Kamath) · kamath.deepak@sjri.res.in · 9945519522
    Contact: Study coordinator (Dr.Belinda George) · georgebelinda@gmail.com · 9845123443
    Contact: Principal Investigator (Dr.Belinda George, MD DM)
    Dr Deepak Y Kamath, MD (Sub-investigator)
    Dr.GRK Sarma, MD DM (Sub-investigator)
    Dr Shifra S, MD (Sub-investigator)
    Dr Yamini VR Priya, MD (Sub-investigator)
    Dr Shruthi Kulkarni, MBBS DNB (Sub-investigator)
    Dr Maria F Bukelo, MD (Sub-investigator)
    Dr Madhukara J, MD (Sub-investigator)
View source on ClinicalTrials.gov(opens in a new tab)